Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.1557
Abstract: In the last decades, new biologic drugs were introduced for the treatment of chronic inflammatory arthropathies, progressively leading to a relevant increase of medical costs. However, the introduction of biosimilars (biologic molecules similar to branded…
read more here.
Keywords:
switch;
originator biosimilar;
etanercept originator;
biosimilar gp2015 ... See more keywords